PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.

Description

A 3-year cluster randomized controlled trial of the impact of a quality improvement and clinical decision support package versus usual care for patients with modifiable high-risk chronic obstructive pulmonary disease with or without a current diagnosis.

Conditions

Chronic Obstructive Pulmonary Disease

Talk to us

Study Overview

On this page

Study Details

Study overview

A 3-year cluster randomized controlled trial of the impact of a quality improvement and clinical decision support package versus usual care for patients with modifiable high-risk chronic obstructive pulmonary disease with or without a current diagnosis.

Pragmatic Evaluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD (PREVAIL)

PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.

Condition
Chronic Obstructive Pulmonary Disease
Intervention / Treatment

-

Contacts and Locations

Denver

University of Colorado, Denver, Colorado, United States, 80309

New York

Mount Sinai, New York, New York, United States, 10029

Cleveland

MetroHealth, Cleveland, Ohio, United States, 44109

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Primary Care Teams (PCTs) must be able to function as a single randomization unit with low risk of contamination between participants and physicians due to the absence of blinding in the intervention (see section 8.8 for details on blinding).
  • * PCT must have a sufficient number of patients meeting modifiable high-risk patient criteria (see section 8.1 on sample size estimates).
  • * PCT must express willingness to be randomized to either receive the CONQUEST program initially, or usual care until program roll-out to the delayed intervention arm.
  • * PCTs that are in the process of, or planning to change EHR software provider or practice ownership within the trial outcome evaluation period
  • * PCTs engaged in active research studies or COPD related Quality Improvement Programs which might impact the ability to implement CONQUEST program.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Observational and Pragmatic Research Institute,

Study Record Dates

2026-12